Search Results 841-850 of 17878 for monoclonal antibody
... monoclonal antibody therapy must have completed that therapy ≥ 6 weeks (or 3 half-lives of the antibody, whichever is shorter) prior to enrollment on ...
Monoclonal antibodies, such as obinutuzumab, may interfere with the ability of cancer cells to grow and spread. It is not yet known whether giving ...
Mayo staff administered more than 19,000 monoclonal antibody infusions for patients with COVID-. 19. • Mayo Clinic Laboratories, which serves health care ...
Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...
... antibody therapy, such as trastuzumab emtansine (T-DM1) and/or pertuzumab ... Monoclonal antibodies, such as pembrolizumab, may block tumor growth in ...
Bevacizumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such ...
Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ...
A condition of blood plasma that produces altered antibodies that increase the risk of blood cancers and other conditions.
Vaccination should be delayed by 90 days for their children who received monoclonal antibody or convalescent plasma or were given the diagnosis of COVID-19 — ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!